Sharp Corp. buy krebskrebs
Start price
17.05.22
/
50%
€1.88
Target price
17.05.23
€2.20
Performance (%)
-24.47%
End price
18.05.23
€1.42
Summary
This prediction ended on 18.05.23 with a price of €1.42. The prediction for Sharp Corp. disappointed with a performance of -24.47%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sharp Corp. | - | - | - | - |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% | 56.827% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% | 83.028% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% | 50.695% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% | 57.560% |
Comments by krebskrebs for this prediction
In the thread Sharp Corp. diskutieren
In the thread Trading Sharp Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten